EDGAR Filing Documents for 0001144204-15-062080

Form 424B3 - Prospectus [Rule 424(b)(3)]:

SEC Accession No. 0001144204-15-062080

Filing Date

2015-11-02

Accepted

2015-11-02 09:00:55

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B3	v423402_424b3.htm	424B3	477602
2	GRAPHIC	tpg35.jpg	GRAPHIC	103274
3	GRAPHIC	tpg37.jpg	GRAPHIC	71928
	Complete submission text file	0001144204-15-062080.txt		720325

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 424B3 | Act: 33 | File No.: 333-207443 | Film No.: 151189460
SIC: 2834 Pharmaceutical Preparations